Edition:
United Kingdom

Fennec Pharmaceuticals Inc (FENC.OQ)

FENC.OQ on NASDAQ Stock Exchange Capital Market

8.90USD
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
$8.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
$13.96
52-wk Low
$8.23

Select another date:

Fri, Dec 8 2017

BRIEF-Fennec Announces Pricing Of Public Offering

* SAYS PUBLIC OFFERING OF 2.35 MILLION COMMON SHARES PRICED AT $8.50PER SHARE Source text for Eikon: Further company coverage:

BRIEF-Fennec Pharmaceuticals Q3 loss per share $0.15‍​

* Fennec provides business update and reports third quarter 2017 results

BRIEF-Fennec pharmaceuticals files for stock shelf of up to $90 mln

* Files for stock shelf of up to $90 million - SEC filing‍​ Source text (http://bit.ly/2h66FIr) Further company coverage:

BRIEF-Fennec announces positive results from phase 3 SIOPEL 6 study on Pedmark

* Fennec announces positive results from phase 3 SIOPEL 6 study on Pedmark (sodium thiosulfate) presented at the 49th Congress of the international Society of Pediatric Oncology (SIOP) 2017 meeting

BRIEF-Fennec announces preliminary results of SIOPEL 6 study on PEDMARK to be presented at SIOP meeting

* Fennec announces preliminary results of SIOPEL 6 study on PEDMARK(sodium thiosulfate) to be presented at the 49th Congress of the International Society Of Pediatric Oncology (SIOP) 2017 meeting

Select another date: